Seeking Alpha

jawdoc19@gmail.com

jawdoc19@gmail.com
Send Message
View as an RSS Feed
View jawdoc19@gmail.com's Comments BY TICKER:
Latest  |  Highest rated
  • Rocket Fuel -29% AH on weak guidance; Criteo, Rubicon Project also off [View news story]
    FUEL very undervalued even at $30. Short seller are comparing this to FEYE. I think its very risky to short this level.Great buying opportunity, I sold SCTY AH and bought FUEL.
    May 8 09:19 PM | Likes Like |Link to Comment
  • SolarCity affirms 2014 guidance, details spending activity [View news story]
    Goldman will repeat conviction buy tomorrow and $SCTY will move back to 80.
    Mar 18 05:17 PM | Likes Like |Link to Comment
  • Intercept down 7% premarket [View news story]
    It will up 5% soon. shorts will be burnt.Medical studies use p-value of 5% for "statistical significance". This means 95% probability adverse effects were due to pure chance. This is great buying opportunity
    Mar 17 08:25 AM | Likes Like |Link to Comment
  • Intercept Pharmaceuticals EPS beats by $0.06, misses on revenue [View news story]
    Medical studies use p-value of 5% for "statistical significance". This means 95% probability adverse effects were due to pure chance. This is great buying opportunity, below 410 would be great.
    Mar 15 07:05 AM | Likes Like |Link to Comment
  • Riding High On AeroGrow [View article]
    Golden opportunity to buy. People took profit who got very cheap. Time to load
    Mar 11 10:24 AM | Likes Like |Link to Comment
  • Best Short Idea In 2014: Organovo Holdings, Inc. [View article]
    Very risky to short. DDD just got upgraded
    Mar 11 09:16 AM | 5 Likes Like |Link to Comment
  • Riding High On AeroGrow [View article]
    Great article Mark. I saw their products at homedepot and amazon. No brainier entry point.
    Mar 10 07:19 AM | 2 Likes Like |Link to Comment
  • SolarCity Poised To Benefit From Tesla Gigafactory [View article]
    $SCTY is poised to run much higher. Many upgrades will follow Monday earnings and gigafactory announcment.
    Feb 28 06:58 AM | Likes Like |Link to Comment
  • AeroGrow CEO: We're Back With A Vengeance [View article]
    I think it will pull back to 6.50 before flying again. Lots of early investors who entered at $2-3 ( 2 months ago) are starting to take profit.
    Feb 24 09:59 PM | Likes Like |Link to Comment
  • Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors [View article]
    Agree with you. Shorts have to cover.
    Feb 23 07:31 PM | 1 Like Like |Link to Comment
  • Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors [View article]
    I think PRAN is low risk reward at this price. There is huge upside and limited downside. Few so called biotech experts (no medical background just twitter basher) are targeting PRAN GALE CHTP and making money.
    Remember PRAN has low float and short squeeze on cards
    Feb 23 08:49 AM | 3 Likes Like |Link to Comment
  • Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors [View article]
    You are lying as per twitter posts. You did short PRAN in morning and actually got scared after release of this article. PRAN looks very promising even in this biotech bubble. PRAN should trade at $18 atleast considering ICPT at $370 & Furx at $96.
    Feb 22 12:58 PM | 19 Likes Like |Link to Comment
  • AeroGrow CEO: We're Back With A Vengeance [View article]
    Great earnings.
    Feb 11 06:36 PM | Likes Like |Link to Comment
  • Glu Mobile jumps after Zynga buys peer [View news story]
    $GLUU will beat earnings estimates, no question. If they raise 2014 guidance stock will jump 50%.
    Feb 2 05:18 PM | Likes Like |Link to Comment
  • Patent And Reimbursement Risks Already Priced In At Myriad Genetics [View article]
    Very low risk reward to buy MYGN at this price. 50% shorts and 90% institutional ownership. Hard to find good stocks in market at all time high.
    Dec 30 01:59 PM | Likes Like |Link to Comment
COMMENTS STATS
36 Comments
41 Likes